# Charm TX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/charm-tx

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.charmtx.com
- Total disclosed funding: $128M
- Latest round: Series B (Aug 2, 2025)
- Investors on record: 9

## About

Based in London, UK, and in 2021 by its CEO, Laksh Aithani, and David Baker, Charm Therapeutics Limited, trading under the name, Charm TX operates as a biotechnology research company that offers therapeutics solutions used for the treatment of cancer. In August 2025, Charm Therapeutics Limited raised EUR 68.5 million in series B funding co-led by new investors New Enterprise Associates and SR One, with participation from returning investors OrbiMed Advisors, F-Prime Capital, Khosla Ventures, and Nventures.

The company offers various artificial intelligence-supported genetic and drug discovery solutions that include macromolecular configurations used to develop transformational medicines. The company uses 3D deep learning co-folding technology to develop the process of making novel small molecules used for the treatment of cancer and other diseases.

The company will use the September 2025 funding for further development of its menin inhibitor into clinical trials.

## Funding rounds

- Series B, Aug 2, 2025, $78M — New Enterprise Associates, OrbiMed Advisors, SR One, Khosla Ventures, F-Prime Capital, Nventures
- Series A, Jun 9, 2022, $50M — OrbiMed Advisors, General Catalyst Partners, Khosla Ventures, F-Prime Capital, Braavos Ventures, Axial VC

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A, Series B
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series A
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A, Series B
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series B
- Braavos Ventures (https://capitalatlas.ai/funds/braavos-ventures) — Series A
- Axial VC (https://capitalatlas.ai/funds/axial-vc) — Series A
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- Nventures — Series B